Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12 Fevereiro 2024 - 7:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
SCHEDULE 13G/A
Under the Securities
Exchange Act of 1934
(Amendment No. 2)
*
Interpace
Biosciences, Inc.
(Name of Issuer)
Common
Stock, $.01 par value
(Title of Class of Securities)
46062X303
(CUSIP Number)
December
31, 2023
(Date of Event which
Requires Filing of this Statement)
Check the appropriate
box to designate the rule pursuant to which this Schedule is filed:
o
Rule 13d-1(b)
o
Rule 13d-1(c)
o
Rule 13d-1(d)
*The remainder of this
cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required
on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange
Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
CUSIP No. 46062X303 | Page 2 of 5 |
1. |
Names of Reporting Persons
I.R.S. Identification Nos. of above Persons (entities only).
Douglas M. Singer |
2. |
Check the Appropriate Box if a Member of a Group (See
Instructions)
(a) o
(b) x
|
3. |
SEC Use Only
|
4. |
Citizenship or Place of Organization
United States |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
5. |
Sole Voting Power
250,000 |
6. |
Shared Voting Power
- 0 - |
7. |
Sole Dispositive Power
250,000 |
8. |
Shared Dispositive Power
- 0 - |
9. |
Aggregate Amount Beneficially Owned by Each Reporting
Person
250,000 |
10. |
Check Box if the Aggregate Amount in Row 9 Excludes
Certain Shares (See Instructions) o
|
11. |
Percent of Class Represented by Amount in Row (9)
5.78% |
12. |
Type of Reporting Person (See Instructions)
IN |
|
|
|
|
CUSIP No. 46062X303 | Page 3 of 5 |
Interpace Biosciences,
Inc.
| (b) | Address of
Issuer’s Principal Executive Offices: |
Waterview Plaza,
Suite 310
2001
Route 46
Parsippany,
NJ 07054
Item 2. |
Name of Person Filing |
Douglas
M. Singer
| (b) | Address of
Principal Business Office: |
9600
North 96th Street Unit 241
Scottsdale,
Arizona 85258
United
States
| (d) | Title of Class
of Securities: |
Common
Stock, $0.01 par value
46062X303
Item 3. |
If this statement is filed pursuant to § 240.13d-1(b) or § 240.13d-2(b) or (c), check whether
the person filing is a: |
| (a) | o
Broker or dealer registered under Section 15 of the
Act. |
| (b) | o
Bank as defined in section 3(a)(6) of the Act. |
| (c) | o
Insurance company as defined in section 3(a)(19) of
the Act. |
| (d) | o
Investment company registered under section 8 of the
Investment Company Act of 1940. |
| (e) | o
An investment adviser in accordance with § 240.13(d)-1(b)(1)(ii)(E). |
| (f) | o
An employee benefit plan or endowment fund in accordance
with § 240.13d-1(b)(1)(ii)(F). |
| (g) | o
A parent holding company or control person in accordance
with § 240.13d-1(b)(ii)(G) |
| (h) | o
A savings association as defined in Section 3(b) of
the Federal Deposit Insurance Act (12 U.S.C. 1813). |
| (i) | o
A church plan that is excluded from the definition of
an investment company under section 3(c)(14) of the Investment Company Act of 1940. |
| (j) | o
Group, in accordance with § 240.13d-1(b)(1)(ii)(J). |
CUSIP No. 46062X303 | Page 4 of 5 |
All ownership information
is as of December 31, 2022.
| (a) | Amount Beneficially
Owned: See Item 9 of Cover Sheet. |
| (b) | Percent of
Class: See Item 11 of Cover Sheet. |
| (c) | Number of
shares as to which the person has: |
| (i) | sole power
to vote of to direct the vote: See Item 5 of Cover Sheet. |
| (ii) | shared
power to vote or to direct the vote: See Item 6 of Cover Sheet. |
| (iii) | sole power
to dispose or to direct the disposition of: See Item 7 of Cover Sheet. |
| (iv) | shared
power to dispose or to direct the disposition of: See Item 8 of Cover Sheet. |
Item 5. |
Ownership of Five Percent or Less of a Class |
If this statement
is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following:
| Item 6. | Ownership
of More than Five Percent on Behalf of Another Person |
Not Applicable.
| Item 7. | Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported on By the
Parent Holding Company |
Not Applicable.
| Item 8. | Identification
and Classification of Member of the Group |
Not Applicable.
| Item 9. | Notice
of Dissolution of Group |
Not Applicable.
Not Applicable.
CUSIP No. 46062X303 | Page 5 of 5 |
Signatures
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete,
and correct.
Dated: February
12, 2024 |
|
/s/ Douglas
M. Singer |
|
|
Douglas
M. Singer |
Interpace Biosciences (QX) (USOTC:IDXG)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Interpace Biosciences (QX) (USOTC:IDXG)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025